These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6112118)

  • 21. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
    Havemann U
    Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M
    Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The stimulant effect of neuroleptics: myth or reality?].
    Colonna L; Petit M
    Encephale; 1979; 5(3):239-42. PubMed ID: 39738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):5-14. PubMed ID: 13315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influences of biological rhythms on the effects of psychotropic drugs.
    Nagayama H
    Psychosom Med; 1999; 61(5):618-29. PubMed ID: 10511012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of classical and atypical neuroleptics on apomorphine-induced behavioural changes and on extinction of a conditioned avoidance response.
    Serra G; Van Ree JM; de Wied D
    J Pharm Pharmacol; 1983 Apr; 35(4):255-7. PubMed ID: 6133940
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice.
    Protais P; Bonnet JJ; Costentin J
    Psychopharmacology (Berl); 1983; 81(2):126-34. PubMed ID: 6138794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the sensitivity of brain dopamine and serotonin receptors during the prolonged administration of carbidine].
    Zharkovskiĭ AM; Chereshka KS; Zharkovskaia TA; Allikmets LKh
    Biull Eksp Biol Med; 1985 Dec; 100(12):719-22. PubMed ID: 2866801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the automated tail suspension test for the primary screening of psychotropic agents.
    Porsolt RD; Chermat R; Lenègre A; Avril I; Janvier S; Stéru L
    Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):11-30. PubMed ID: 2889430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390.
    Gessa GL; Porceddu ML; Collu M; Mereu G; Serra M; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Feb; 109(2):269-74. PubMed ID: 2859998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of yohimbine and neuroleptics on apomorphine-induced pecking behaviour in the pigeon.
    Akbas O; Verimer T; Onur R; Kayaalp SO
    Neuropharmacology; 1984 Nov; 23(11):1261-4. PubMed ID: 6152018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic inhibition of adrenergic neurotransmission as a model for studies on dopamine receptor mechanisms.
    Steinsland OS; Hieble JP
    Science; 1978 Jan; 199(4327):443-5. PubMed ID: 22933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The importance of circadian periodicity factors for the action of psychotropic substances].
    Arushanian EB
    Farmakol Toksikol; 1984; 47(3):13-25. PubMed ID: 6145620
    [No Abstract]   [Full Text] [Related]  

  • 36. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M; Leonard BE
    J Neurosci Res; 1980; 5(4):291-8. PubMed ID: 6107385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile.
    Needham PL; Atkinson J; Skill MJ; Heal DJ
    Psychopharmacol Bull; 1996; 32(1):123-8. PubMed ID: 8927661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychoactive drug interactions.
    Gaultieri CT; Powell SF
    J Clin Psychiatry; 1978 Sep; 39(9):720-9. PubMed ID: 29033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that apomorphine and pergolide induce rotation in rats by different actions on D1 and D2 receptor sites.
    Herrera-Marschitz M; Ungerstedt U
    Eur J Pharmacol; 1984 Feb; 98(2):165-76. PubMed ID: 6143675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D1 and D2 dopamine receptors.
    Bo P; Ongini E; Giorgetti A; Savoldi F
    Neuropharmacology; 1988 Aug; 27(8):799-805. PubMed ID: 2905785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.